Pfizer CEO says could be seeking regulatory approval for vaccine in October, possible to have 100 mil doses this year

The Washington Post interviewed Pfizer CEO Albert Bourla about a Covid-19 vaccine that could be ready this year:

In a Washington Post Live interview,Pfizer CEO Albert Bourla, DVM, PhDsaid the company couldseek regulatory approval for their coronavirus vaccine as soon as October. Bourla said patients progress would be tracked for over two years.According to Bourla, the company could have approximately 100 million doses this year, which Americans would receive from the government for free. Pfizers contract with the United States government is priced at $19.50 per dose.

In response to President Trump saying a vaccine could be ready as early as November, Bourla said Pfizer could begin seeking regulatory approval for their coronavirus vaccine as soon as October, allowing for potential distribution in November. Bourla said Pfizer would have approximately 100 million doses manufactured this year globally and a big chunk of that will come to the U.S.

Pfizer CEO Albert Bourla says his company could begin seeking regulatory approval for their #coronavirus vaccine as soon as October, and they would have 100 million doses manufactured this year. https://t.co/hOumc3xZgC pic.twitter.com/uYgnJNjBJA

— Washington Post Live (@postlive) August 6, 2020

If the product works, we have already started manufacturing so that we will have available quantities that would be readily availableWe expect, given how fast the regulatory agencies all over the world are reviewing those applications, that well do it very quickly.

Bourla said as part of Pfizers contract with the U.S. government, Americans will receive the first doses of the vaccine allotted to the United States for free: We took that into consideration, thats why we provided [the U.S.